Ridgeland, MS, United States of America

Ashton T Hamme, Ii


Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Ashton T. Hamme, II

Introduction

Ashton T. Hamme, II is a distinguished inventor based in Ridgeland, MS, whose contributions to the field of anticoagulant therapy have generated significant interest within the scientific community. With a total of five patents, his work primarily focuses on developing compounds that inhibit the coagulation cascade, highlighting his expertise in medicinal chemistry and pharmaceutical innovations.

Latest Patents

One of Ashton’s latest patents is centered around "Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade." This invention pertains to creating new compounds that serve as inhibitors of serine proteases within the coagulation pathway, offering insights into potential treatments for various thrombotic conditions such as coronary artery and cerebrovascular diseases.

Another noteworthy patent from Ashton is titled "Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade." Similar to his previous invention, this patent describes innovative compounds aimed at providing therapeutic solutions through anticoagulant treatments, reinforcing his commitment to addressing critical health issues.

Career Highlights

Currently, Ashton is employed at Pharmacia Corporation, where he applies his skills and knowledge to advance research in pharmacology and drug development. His efforts at Pharmacia Corporation significantly contribute to the company's goal of innovating in the field of therapeutic solutions, especially in managing thrombotic disorders.

Collaborations

Throughout his career, Ashton has had the pleasure of collaborating with noted colleagues such as Michael S. South and Melvin L. Rueppel. These partnerships have fostered an environment of shared expertise and innovative thinking, enabling the development of groundbreaking solutions in anticoagulant therapies.

Conclusion

Ashton T. Hamme, II's innovative spirit and dedication to research have positioned him as a notable figure in the field of medicinal chemistry. With a solid patent portfolio and impactful collaborations, he continues to contribute to advancements that hold the promise of improving patient care in thrombotic conditions. His work at Pharmacia Corporation only furthers his influence within the industry and the scientific community at large.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…